Premium
Drugs in salmonid aquaculture – A review
Author(s) -
Burka J. F.,
Hammell K. L.,
Horsberg T. E.,
Johnson G. R.,
Rainnie D. J.,
Speare D. J.
Publication year - 1997
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1046/j.1365-2885.1997.00094.x
Subject(s) - fish <actinopterygii> , aquaculture , drug , risk analysis (engineering) , pharmaceutical industry , drug development , intensive care medicine , pharmacology , fishery , medicine , biology
In contrast to mammalian therapeutics, the use of pharmaceutical substances is rather limited in fish. It is basically restricted to anaesthetic agents and anti‐infective agents for parasitic and microbial diseases. Anaesthetic agents are used primarily in fish farm and laboratory settings to provide analgesia and immobilization of fish for minor procedures. The anti‐infective agents are used for controlling disease and the choice of drug depends on efficacy, ease of application, human safety, target animal safety including stress to the fish, environmental impact, regulatory approval, costs, and implications for marketing the fish. In this article, the major drugs used in salmonids in North America and Europe will be reviewed and some insight into future directions for drug development and use for the salmonid industry will be introduced. The mechanisms of action, pharmacokinetics, side effects, and uses of the drugs are emphasized.